Abstract
The gut microbiome is one of the main factors affecting human health. It has been proven that probiotics can regulate the metabolism in the host body. A large number of people use probiotics not as medicines, but as a prophylactic supplement. The aim of our study was to evaluate the effect of lactic acid bacteria on the gut microbiome of healthy people using the V3 region of the 16S rRNA gene. Our study showed changes in the generic composition in the gut of healthy people when taking the supplement. There was an increase in the members responsible for the production of short-chain fatty acids in the gut of the host (Blautia, Fusicatenibacter, Eubacterium hallii group, Ruminococcus), as well as bacteria that improve intestinal homeostasis (Dorea and Barnesiella). There was also a decrease in the abundance of bacteria in the genera Catenibacterium, Hungatella, Escherichia-Shigella, and Pseudomonas, associated with an unhealthy profile of the human gut microbiome. An increase in members of the phylum Actinobacteriota was also observed, which has a positive effect on the host organism. Our results indicate that short-term prophylactic use of lactic acid bacteria-based supplements can be effective, as it contributes to a beneficial effect on the gut microbiome of healthy people.
Similar content being viewed by others
Data Availability
Sequencing data is available in NCBI BioProject database (BioProject:PRJNA 860108).
References
Hemarajata P, Versalovic J (2013) Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol 6:39. https://doi.org/10.1177/1756283X12459294
Gopalakrishnan V, Helmink BA, Spencer CN et al (2018) The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell 33:570–580. https://doi.org/10.1016/J.CCELL.2018.03.015
Shadnoush M, Hosseini RS, Khalilnezhad A et al (2015) Effects of probiotics on gut microbiota in patients with inflammatory bowel disease: a double-blind, placebo-controlled clinical trial. Korean J Gastroenterol 65:215–221. https://doi.org/10.4166/KJG.2015.65.4.215
Salem I, Ramser A, Isham N, Ghannoum MA (2018) The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. https://doi.org/10.3389/FMICB.2018.01459
Zukiewicz-Sobczak W, Wróblewska P, Adamczuk P, Silny W (2014) Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases. Cent J Immunol 39:113–117. https://doi.org/10.5114/CEJI.2014.42134
Srinivas D, Mital BK, Garg SK (1990) Utilization of sugars by Lactobacillus acidophilus strains. Int J Food Microbiol 10:51–57. https://doi.org/10.1016/0168-1605(90)90007-R
Sun J, Buys N (2015) Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials. Ann Med 47:430–440. https://doi.org/10.3109/07853890.2015.1071872
Cho YA, Kim J (2015) Effect of probiotics on blood lipid concentrations: a meta-analysis of randomized controlled trials. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000001714
Goldenberg JZ, Ma SSY, Saxton JD et al (2013) Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006095.PUB3
Grandy G, Medina M, Soria R et al (2010) Probiotics in the treatment of acute rotavirus diarrhea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis. https://doi.org/10.1186/1471-2334-10-253
Chitapanarux I, Chitapanarux T, Traisathit P et al (2010) Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. https://doi.org/10.1186/1748-717X-5-31
Bested AC, Logan AC, Selhub EM (2013) Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part II - contemporary contextual research. Gut Pathog. https://doi.org/10.1186/1757-4749-5-3
Bixquert Jiménez M (2009) Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Rev Esp Enferm Dig 101:553–564. https://doi.org/10.4321/S1130-01082009000800006
Naghmouchi K, Belguesmia Y, Bendali F et al (2020) Lactobacillus fermentum: a bacterial species with potential for food preservation and biomedical applications. Crit Rev Food Sci Nutr. https://doi.org/10.1080/10408398.2019.1688250
Li W, Yang L, Nan W et al (2020) Whole-genome sequencing and genomic-based acid tolerance mechanisms of Lactobacillus delbrueckii subsp. bulgaricus LJJ. Appl Microbiol Biotechnol. https://doi.org/10.1007/s00253-020-10788-5
Jan G, Tarnaud F, do Carmo FLR et al (2022) The stressing life of Lactobacillus delbrueckii subsp. bulgaricus in soy milk. Food Microbiol. https://doi.org/10.1016/j.fm.2022.104042
Washburn RL, Sandberg D, Gazdik Stofer MA (2022) Supplementation of a single species probiotic does not affect diversity and composition of the healthy adult gastrointestinal microbiome. Hum Nutr Metab 28:200148. https://doi.org/10.1016/J.HNM.2022.200148
Kim SW, Suda W, Kim S et al (2013) Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res 20:241–253. https://doi.org/10.1093/DNARES/DST006
Volokh O, Klimenko N, Berezhnaya Y et al (2019) Human gut microbiome response induced by fermented dairy product intake in healthy volunteers. Nutrients. https://doi.org/10.3390/NU11030547
Krogius-Kurikka L, Lyra A, Malinen E et al (2009) Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. https://doi.org/10.1186/1471-230X-9-95
Salonen A, De Vos WM, Palva A (2010) Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 156:3205–3215. https://doi.org/10.1099/MIC.0.043257-0
Liu X, Mao B, Gu J et al (2021) Blautia-a new functional genus with potential probiotic properties? Gut Microbes 13:1–21. https://doi.org/10.1080/19490976.2021.1875796
Khattab MSA, Abd El Tawab AM, Fouad MT (2017) Isolation and characterization of anaerobic bacteria from frozen rumen liquid and its potential characterizations. Int J Dairy Sci 12:47–51. https://doi.org/10.3923/IJDS.2017.47.51
Kim M, Kim N, Han J (2014) Metabolism of Kaempferia parviflora polymethoxyflavones by human intestinal bacterium Bautia sp. MRG-PMF1. J Agric Food Chem 62:12377–12383. https://doi.org/10.1021/JF504074N
Laverde Gomez JA, Mukhopadhya I, Duncan SH et al (2019) Formate cross-feeding and cooperative metabolic interactions revealed by transcriptomics in co-cultures of acetogenic and amylolytic human colonic bacteria. Environ Microbiol 21:259–271. https://doi.org/10.1111/1462-2920.14454
Maturana JL, Cárdenas JP (2021) Insights on the evolutionary genomics of the Blautia genus: potential new species and genetic content among lineages. Front Microbiol. https://doi.org/10.3389/FMICB.2021.660920
Hamajima H, Matsunaga H, Fujikawa A et al (2016) Japanese traditional dietary fungus koji Aspergillus oryzae functions as a prebiotic for Blautia coccoides through glycosylceramide: Japanese dietary fungus koji is a new prebiotic. Springerplus. https://doi.org/10.1186/S40064-016-2950-6
Takada T, Kurakawa T, Tsuji H, Nomoto K (2013) Fusicatenibacter saccharivorans gen. nov., sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 63:3691–3696. https://doi.org/10.1099/IJS.0.045823-0
Takeshita K, Mizuno S, Mikami Y et al (2016) A single species of Clostridium subcluster XIVa decreased in ulcerative colitis patients. Inflamm Bowel Dis 22:2802–2810. https://doi.org/10.1097/MIB.0000000000000972
Hou Q, Zhao F, Liu W et al (2020) Probiotic-directed modulation of gut microbiota is basal microbiome dependent. Gut Microbes. https://doi.org/10.1080/19490976.2020.1736974
Rapozo DCM, Bernardazzi C, De Souza HSP (2017) Diet and microbiota in inflammatory bowel disease: the gut in disharmony. World J Gastroenterol 23:2124–2140. https://doi.org/10.3748/WJG.V23.I12.2124
Sprague R (2017) Fusicatenibacter is associated with kefir drinking. bioRxiv. https://doi.org/10.1101/218313
Yang P, Li Z, DENG TK et al (2021) Effects of probiotics supplementation on placental microbiome in healthy women undergoing spontaneous delivery. https://doi.org/10.21203/RS.3.RS-418396/V1
Engels C, Ruscheweyh HJ, Beerenwinkel N et al (2016) The common gut microbe Eubacterium hallii also contributes to intestinal propionate formation. Front Microbiol. https://doi.org/10.3389/FMICB.2016.00713
Duncan SH, Louis P, Flint HJ (2004) Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 70:5810–5817. https://doi.org/10.1128/AEM.70.10.5810-5817.2004
Udayappan S, Manneras-Holm L, Chaplin-Scott A et al (2016) Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ Biofilms Microbiomes. https://doi.org/10.1038/NPJBIOFILMS.2016.9
Almeida D, Machado D, Andrade JC et al (2020) Evolving trends in next-generation probiotics: a 5W1H perspective. Crit Rev Food Sci Nutr 60:1783–1796. https://doi.org/10.1080/10408398.2019.1599812
Guhathakurta S (2017) Optimization of growth conditions of “eubacterium Hallii” as a potential probiotics. Wayne State Univ Theses
Tian T, Zhang X, Luo T et al (2021) Effects of short-term dietary fiber intervention on gut microbiota in young healthy people. Diabetes Metab Syndr Obes 14:3507–3516. https://doi.org/10.2147/DMSO.S313385
La Reau AJ, Suen G (2018) The Ruminococci: key symbionts of the gut ecosystem. J Microbiol 56:199–208. https://doi.org/10.1007/S12275-018-8024-4
Chng KR, Ghosh TS, Tan YH et al (2020) Metagenome-wide association analysis identifies microbial determinants of post-antibiotic ecological recovery in the gut. Nat Ecol Evol 4:1256–1267. https://doi.org/10.1038/S41559-020-1236-0
Park W (2018) Gut microbiomes and their metabolites shape human and animal health. J Microbiol 56:151–153. https://doi.org/10.1007/S12275-018-0577-8
Li Y, Hintze KJ, Ward RE (2021) Effect of supplemental prebiotics, probiotics and bioactive proteins on the microbiome composition and fecal calprotectin in C57BL6/j mice. Biochimie 185:43–52. https://doi.org/10.1016/J.BIOCHI.2021.02.010
Piquer-Esteban S, Ruiz-Ruiz S, Arnau V et al (2021) Exploring the universal healthy human gut microbiota around the World. Comput Struct Biotechnol J 20:421–433. https://doi.org/10.1016/J.CSBJ.2021.12.035
Gevers D, Kugathasan S, Denson LA et al (2014) The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15:382–392. https://doi.org/10.1016/J.CHOM.2014.02.005
Shen XJ, Rawls JF, Randall T et al (2010) Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1:138–147. https://doi.org/10.4161/GMIC.1.3.12360
Luo M, Liu Q, Xiao L, Xiong L-S (2022) Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation. J Health Popul Nutr. https://doi.org/10.1186/S41043-022-00302-0
Mancabelli L, Milani C, Lugli GA et al (2017) Meta-analysis of the human gut microbiome from urbanized and pre-agricultural populations. Environ Microbiol 19:1379–1390. https://doi.org/10.1111/1462-2920.13692
Kulagina EV, Efimov BA, Maximov PY et al (2012) Species composition of Bacteroidales order bacteria in the feces of healthy people of various ages. Biosci Biotechnol Biochem 76:169–171. https://doi.org/10.1271/BBB.110434
Ubeda C, Bucci V, Caballero S et al (2013) Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 81:965–973. https://doi.org/10.1128/IAI.01197-12
Kaakoush NO (2015) Insights into the role of Erysipelotrichaceae in the human host. Front Cell Infect Microbiol. https://doi.org/10.3389/FCIMB.2015.00084
Mancabelli L, Milani C, Lugli GA et al (2017) Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. FEMS Microbiol Ecol. https://doi.org/10.1093/FEMSEC/FIX153
Wei X, Tao J, Xiao S et al (2018) Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota. Sci Rep. https://doi.org/10.1038/S41598-018-22094-2
Esber N, Mauras A, Delannoy J et al (2020) Three candidate probiotic strains impact gut microbiota and induce anergy in mice with cow’s milk allergy. Appl Environ Microbiol. https://doi.org/10.1128/AEM.01203-20
Duar RM, Lin XB, Zheng J et al (2017) Lifestyles in transition: evolution and natural history of the genus Lactobacillus. FEMS Microbiol Rev 41:S27–S48. https://doi.org/10.1093/FEMSRE/FUX030
Mu Q, Tavella VJ, Luo XM (2018) Role of Lactobacillus reuteri in human health and diseases. Front Microbiol. https://doi.org/10.3389/FMICB.2018.00757
Ghosh TS, Arnoux J, O’Toole PW (2020) Metagenomic analysis reveals distinct patterns of gut lactobacillus prevalence, abundance, and geographical variation in health and disease. Gut Microbes 12:1–19. https://doi.org/10.1080/19490976.2020.1822729
Shin JH, Sim M, Lee JY, Shin DM (2016) Lifestyle and geographic insights into the distinct gut microbiota in elderly women from two different geographic locations. J Physiol Anthropol. https://doi.org/10.1186/S40101-016-0121-7
Hou YP, He QQ, Ouyang HM et al (2017) Human gut microbiota associated with obesity in chinese children and adolescents. Biomed Res Int. https://doi.org/10.1155/2017/7585989
Pinart M, Dötsch A, Schlicht K et al (2021) Gut microbiome composition in obese and non-obese persons: a systematic review and meta-analysis. Nutrients. https://doi.org/10.3390/NU14010012
Martínez-Cuesta MC, del Campo R, Garriga-García M et al (2021) Taxonomic characterization and short-chain fatty acids production of the obese microbiota. Front Cell Infect Microbiol. https://doi.org/10.3389/FCIMB.2021.598093
Brahe LK, Le Chatelier E, Prifti E et al (2015) Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diabetes. https://doi.org/10.1038/NUTD.2015.9
Kaur S, Yawar M, Kumar PA, Suresh K (2014) Hungatella effluvii gen. nov., sp. nov., an obligately anaerobic bacterium isolated from an effluent treatment plant, and reclassification of Clostridium hathewayi as Hungatella hathewayi gen. nov., comb. nov. Int J Syst Evol Microbiol 64:710–718. https://doi.org/10.1099/IJS.0.056986-0
Hernández-Juárez LE, Camorlinga M, Méndez-Tenorio A et al (2021) Analyses of publicly available Hungatella hathewayi genomes revealed genetic distances indicating they belong to more than one species. Virulence 12:1950–1964. https://doi.org/10.1080/21505594.2021.1950955
Randazzo A, Kornreich A, Lissoir B (2015) A Clostridium hathewayi isolate in blood culture of a patient with an acute appendicitis. Anaerobe 35:44–47. https://doi.org/10.1016/J.ANAEROBE.2015.07.003
Aron-Wisnewsky J, Prifti E, Belda E et al (2019) Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut 68:70–82. https://doi.org/10.1136/GUTJNL-2018-316103
Sbierski-Kind J, Grenkowitz S, Schlickeiser S et al (2022) Effects of caloric restriction on the gut microbiome are linked with immune senescence. Microbiome. https://doi.org/10.1186/S40168-022-01249-4
Baltazar-Díaz TA, González-Hernández LA, Aldana-Ledesma JM et al (2022) Escherichia/ Shigella, SCFAs, and metabolic pathways-the triad that orchestrates intestinal dysbiosis in patients with decompensated alcoholic cirrhosis from western Mexico. Microorganisms 10:1231. https://doi.org/10.3390/MICROORGANISMS10061231
Castaño-Rodríguez N, Underwood AP, Merif J et al (2018) Gut microbiome analysis identifies potential etiological factors in acute gastroenteritis. Infect Immun. https://doi.org/10.1128/IAI.00060-18
Guo W, Zhang Y, Guo S et al (2021) Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Commun Biol. https://doi.org/10.1038/S42003-021-02557-5
Markou P, Apidianakis Y (2014) Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer. Front Cell Infect Microbiol. https://doi.org/10.3389/FCIMB.2013.00115
Rubio-Gómez JM, Santiago CM, Udaondo Z et al (2020) Full transcriptomic response of Pseudomonas aeruginosa to an inulin-derived fructooligosaccharide. Front Microbiol. https://doi.org/10.3389/FMICB.2020.00202
Funding
This work was supported by Ministry of Science and Higher Education of the Russian Federation in the framework of the national project “Science” (project FZGW-2020–0001, unique number of the register of State tasks 075001X39782002).
Author information
Authors and Affiliations
Contributions
Conceptualization: M.S., E.P., and V.P.; methodology: M.S. and E.P.; software: M.G.; validation: M.G. and Yu.S.; formal analysis: M.G., I.B., and Yu.S.; investigation: I.B. and Yu.S.; resources: M.S., P.Ch., and V.P.; data curation: M.G. and Yu.S.; writing—original draft preparation: M.G., Yu.S., I.B., and P.Ch.; writing—review and editing: M.S. and V.P.; visualization: M.G. and I.B.; supervision: M.S. and V.P.; project administration: V.P.; funding acquisition: V.P. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethics Board of Voronezh State University (Protocol N42-03, March 7, 2022).
Consent to Participate
Informed consent was obtained from all subjects involved in the study.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gryaznova, M., Smirnova, Y., Burakova, I. et al. Changes in the Human Gut Microbiome Caused by the Short-Term Impact of Lactic Acid Bacteria Consumption in Healthy People. Probiotics & Antimicro. Prot. (2023). https://doi.org/10.1007/s12602-023-10111-4
Accepted:
Published:
DOI: https://doi.org/10.1007/s12602-023-10111-4